Genentech ยท 2 hours ago
Postdoctoral Fellow - Computational Biology / Research Oncology, Yao/ De Sauvage Lab
South San Francisco, CA
Full-time
Hybrid
New Grad
$110K/yr - $120K/yrGenentech is a leading biotechnology company focused on advancing science for better health. They are seeking a highly motivated postdoctoral fellow to investigate the interactions between oncogenic pathways and lineage factors in cancer biology, utilizing both computational and wet lab approaches.
BiotechnologyLife ScienceManufacturing
Hiring Manager
Pam Leung
Responsibilities
Utilize in vivo cancer models to understand changes in the chromatin after the acquisition of driver mutations and/or treatment with cancer therapeutics
Analyze single cell and bulk omics datasets to form hypotheses and derive biological insights
Learn best practices in data analysis and potentially software development
Collaborate effectively within an interdisciplinary team of quantitative, experimental, and clinical scientists
Present complex results clearly and concisely to diverse audiences
Qualification
Required
Ph.D. in Cancer Biology, Computational Biology or related field
Experience with in vivo cancer models (e.g. GEMM, xenograft) and in vitro cancer assays
Experience with bulk and/or single-cell omics data analysis (e.g. bulk RNA-seq, ATAC-seq, ChIP-seq and single-cell RNA-seq/ATAC-seq)
Proficiency in R or Python is required
Demonstrated ability to drive at least one key research project, as evidenced by first-author publications in high-impact journals
Strong communication skills and ability to work in a team environment
Benefits
Relocation benefits are available for this job posting.
Competitive salaries and fully funded research expenses
Access to world-class seminars
Professional development workshops
Networking opportunities
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-07
MarketScreener
2026-01-06
Company data provided by crunchbase